Seqirus

CSL Behring Kankakee Illinois site
Pharma

CSL cuts FY26 revenue projection by $600M, writes off $5B

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and is taking a $5 billion asset impairment.
Kevin Dunleavy May 11, 2026 11:30am
image of CSLs new RD facility

CSL details sales slide behind recent leadership transition

Feb 12, 2026 8:29am
Open door symbolizing exit

Beleaguered CSL announces surprise CEO retirement

Feb 10, 2026 10:45am
yellow light street light traffic pause slow delay

CSL delays vax unit spinoff as US immunization rates plummet

Oct 28, 2025 10:00am
HHS Secretary Robert F Kennedy Jr addresses the Gavi global summit

HHS signs off on recommendation to ban thimerosal from vaccines

Jul 23, 2025 3:03pm
An artists depiction of an orange chicken pulling what is presumably a large influenza virus particle

CSL Seqirus picks up its 5th bird-flu-related BARDA award

Sep 26, 2024 3:50pm